Quantcast
Last updated on May 28, 2012 at 16:11 EDT

Get a Comprehensive Insight into the National Sales of the Pharmaceutical Market in Canada

April 4, 2008
Repost This

Research and Markets (http://www.researchandmarkets.com/reports/c87749) has announced the addition of “IMS World Review Country Profile — Canada” to their offering.

IMS Health’s Country Profiles provide a comprehensive insight into the national sales of the pharmaceutical market in selected countries over 5 years. Each individual IMS Company Profile analyzes the critical components that make up a pharmaceutical company, providing you with a clear assessment of the relative strengths and weaknesses of a company’s business strategy. Sales performance is analysed in terms of geographic region, major corporations, therapeutic classes, major products and new product activity.

All data is available over a 5 year period for easy trend analysis and is based on Quarter 4 sales figures.

Products mentioned:

– ALTACE

– CRESTOR

– EFFEXOR XR

– EPREX

– LIPITOR

– LOSEC

– NORVASC

– PANTOLOC

– PLAVIX

– ZYPREXA

Companies Mentioned:

– Pfizer

– Astrazeneca

– Apotex Inc

– Glaxosmithkline

– Janssen-Ortho Inc

– Sanofi-Aventis

– Novartis Pharma

– Roche

– Lilly

– Wyeth Pharmaceutic

– Novopharm

– Schering Health Ca

– Amgen

– Genpharm Pharm

– Ratiopharm

– Bms-Sanofi

– Bayer Pharma

– Abbott Pcd

– Altana Pharma Inc

– Boehringer Ing

– Ms&D

– Pharmascience

– Pfizer Consumer Hc

– Frosst

– Purdue Pharma

– Wyeth Cons Hc

– P&G Pharma

– Sandoz Canada Inc

– Bms Pharma

– Mcneil Consumer

– Lifescan

– Novo Nordisk Cda

– Berlex Canada

– Roche Diagnostics

– Abbott Spd

For more information, visit http://www.researchandmarkets.com/reports/c87749